SB387

To Authorize Off-label Use Of Drug Treatments To Treat Medicaid Beneficiaries With Pediatric Acute-onset Neuropsychiatric Syndrome And Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infection.

To Authorize Off-label Use Of Drug Treatments To Treat Medicaid Beneficiaries With Pediatric Acute-onset Neuropsychiatric Syndrome And Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infection.